Lv1
10 积分 2026-06-24 加入
Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand
2个月前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
2个月前
已完结
PLK1 stabilizes β-catenin to drive colorectal carcinogenesis through NFKB2-mediated transcriptional activation of USP2a and site-specific phosphorylation
2个月前
已完结
PLK1 stabilizes β-catenin to drive colorectal carcinogenesis through NFKB2-mediated transcriptional activation of USP2a and site-specific phosphorylation
2个月前
已完结
皖公网安备34019202002308
